Beta Bionics, Inc.·4

Sep 8, 6:15 PM ET

Feider Stephen 4

4 · Beta Bionics, Inc. · Filed Sep 8, 2025

Insider Transaction Report

Form 4
Period: 2025-09-05
Feider Stephen
Chief Financial Officer
Transactions
  • Exercise/Conversion

    Common Stock

    2025-09-05$5.10/sh+100$51044,141 total
  • Exercise/Conversion

    Employee Stock Option (right to buy)

    2025-09-0510099,595 total
    Exercise: $5.10Exp: 2033-09-13Common Stock (100 underlying)
  • Sale

    Common Stock

    2025-09-05$21.00/sh100$2,10044,041 total
Footnotes (2)
  • [F1]Represents shares sold pursuant to a Rule 10b5-1 Plan adopted on May 15, 2025.
  • [F2]The shares subject to this option shall vest in 48 equal monthly installments measured from September 14, 2023.

Documents

1 file
  • 4
    form4-09082025_060901.xmlPrimary